← Leaderboards
William J Harrington
University Of Miami School Of Medicine
$5,964,578
Attributed
$5,964,578
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $987K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$5,964,578 · 7
By mechanism
R01$3,404,930 · 3
U01$1,434,718 · 2
K24$684,290 · 1
K12$440,640 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Kelvin P Lee$20,240,939
- Afoma Chinyelu Umeano$202,832
- Glen N. Barber$22,145,694
- Juan Carlos Ramos$5,743,042
- Mark Daniel Pegram$1,014,461
Others in their field
Top investigators on “Aids Related Neoplasm /Cancer”
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$15,689,743
- Joseph B. Margolick · Johns Hopkins University$13,575,779
- Robert L. Murphy · Northwestern University$13,176,178
- Charles L Loprinzi · Mayo Clinic Coll Of Medicine, Rochester$12,706,969
Research focus
Aids Related Neoplasm /CancerZidovudineApoptosisInterferon AlphaCombination ChemotherapyNonhodgkin'S LymphomaHuman SubjectHuman Therapy EvaluationClinical ResearchLymphomaAntiviral AgentsKaposi'S SarcomaPolymerase Chain ReactionGene TherapyTissue Resource /RegistryNeoplasm /Cancer DiagnosisNeoplasm /Cancer TherapyGammaherpesvirinaeVirus GeneticsHuman Immunodeficiency VirusHuman TissueClinical TrialsAidsAids Therapy
Grant awards (28)
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$285,459
R01 · FY2007 · CA · contact PI
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings$248,486
R01 · FY2007 · CA · contact PI
Targeting of EBV Latency in Burkitt's Lymphoma$236,524
R01 · FY2007 · CA · contact PI
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$293,984
R01 · FY2006 · CA · contact PI
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings$281,770
R01 · FY2006 · CA · contact PI
Targeting of EBV Latency in Burkitt's Lymphoma$261,905
R01 · FY2006 · CA · contact PI
University of Miami$149,329
U01 · FY2006 · CA · contact PI
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$301,059
R01 · FY2005 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$150,000
U01 · FY2005 · CA
Viral Oncology Career Development Grant$136,858
K24 · FY2005 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$90,900
U01 · FY2005 · CA
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$301,059
R01 · FY2004 · CA
Viral Oncology Career Development Grant$136,858
K24 · FY2004 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$79,686
U01 · FY2004 · CA
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$313,934
R01 · FY2003 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$231,968
U01 · FY2003 · CA
Viral Oncology Career Development Grant$136,858
K24 · FY2003 · CA
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma$100,000
R01 · FY2003 · CA
ANTIVIRAL MEDIATED APOPTOSIS OF NON HODGKIN'S LYMPHOMA$256,500
R01 · FY2002 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$227,600
U01 · FY2002 · CA
Viral Oncology Career Development Grant$136,858
K24 · FY2002 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$66,801
U01 · FY2002 · CA
ANTIVIRAL MEDIATED APOPTOSIS OF NON HODGKIN'S LYMPHOMA$256,500
R01 · FY2001 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$223,358
U01 · FY2001 · CA
Viral Oncology Career Development Grant$136,858
K24 · FY2001 · CA
MIAMI AIDS ONCOLOGY SCIENTIST PROGRAM$440,640
K12 · FY2000 · CA
ANTIVIRAL MEDIATED APOPTOSIS OF NON HODGKIN'S LYMPHOMA$267,750
R01 · FY2000 · CA
SOUTHEASTERN AIDS ONCOLOGY CONSORTIUM$215,076
U01 · FY2000 · CA